MolecuLight's Pioneering Fluorescence Imaging Technology Showcased in Prestigious Burns Journal in Novel Study
Published on 08/07/2025 at 18:08 | prnewswire.co.uk
which includes two CPT® codes for physician work to perform "fluorescence imaging for bacterial presence, location, and load" and facility payment for Hospital Outpatient Department (HOPD) and Ambulatory Surgical Center (ASC) settings through an Ambulatory Payment Classification (APC) assignment. The company is also commercializing its unique fluorescence imaging platform technology for other global markets with relevant unmet needs in food safety, consumer cosmetics, and other key industrial markets.
For sales, media or other inquiries or further information, please contact
Carolina Wuesthoff, MD
Global Manager, Medical Engagement & Communications
MolecuLight Inc.
cwuesthoff@moleculight.com
T. +1.647.362.4684
www.moleculight.com
View original content:https://www.prnewswire.co.uk/news-releases/moleculights-pioneering-fluorescence-imaging-technology-showcased-in-prestigious-burns-journal-in-novel-study-302157994.html
en | boerse | 67926372 |
